Akebia Therapeutics Inc. (AKBA) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-10
10:30 am
Purchase
2020-12-3113GAkebia Therapeutics, Inc.
AKBA
VANGUARD GROUP INC8,434,759
5.840%
8,434,759increase
(New Position)
Filing
History
2021-02-10
10:26 am
Purchase
2021-01-3113GAkebia Therapeutics, Inc.
AKBA
STATE STREET CORP
STT
22,817,170
15.790%
7,476,699increase
(+48.74%)
Filing
History
2021-02-03
1:33 pm
Sale
2020-12-3113GAkebia Therapeutics, Inc.
AKBA
WELLINGTON MANAGEMENT GROUP LLP12,590,463
8.710%
-5,107,650decrease
(-28.86%)
Filing
History
2021-01-28
5:56 pm
Purchase
2020-12-3113GAkebia Therapeutics, Inc.
AKBA
BlackRock Inc.
BLK
11,397,548
7.900%
1,136,401increase
(+11.07%)
Filing
History
Goto Prev, 0, 1